A 16-year-old adolescent received routine immunizations 2 hours ago and is now complaining of headache and fever of 102.5°F (39.2°C). The parents are concerned and ask the nurse what they should do. What is the most appropriate initial nursing assessment?

Obtaining vital signs and assessing neurological status is the initial priority to establish baseline data and identify serious complications like febrile seizures. Other options target specific areas but are secondary to a comprehensive assessment.

Understanding the Clinical Scenario
The scenario describes a 16-year-old adolescent who, 2 hours after receiving routine immunizations, develops a headache and a fever of 102.5°F (39.2°C). The parents are anxious and seeking guidance. The core of the question is identifying the most appropriate initial nursing assessment when a post-vaccination systemic reaction is reported.

Prioritizing the Nursing Assessment
In a situation where a patient presents with a fever and headache shortly after immunization, the nurse must first differentiate between a common, self-limiting adverse event following immunization (AEFI) and a rare but potentially serious reaction. The priority is to establish a baseline of the patient's physiological stability and screen for neurological red flags. The reference study on the TAK-003 vaccine highlights that AEFIs are systematically classified by severity and type, with neurological events being a critical category for surveillance ^[1]. Therefore, the immediate nursing action is to perform a focused assessment of the patient’s vital signs and neurological status to rule out serious conditions such as an evolving neurological complication or systemic inflammatory response.

Rationale for the Correct Answer (Option 4)
Assessing vital signs and neurological status is the most appropriate first step because it directly addresses the presenting symptoms (fever and headache) and screens for the most concerning potential complications. The fever of 102.5°F (39.2°C) is a documented systemic reaction, but it requires a complete set of vital signs—including heart rate, respiratory rate, and blood pressure—to evaluate for signs of systemic involvement or sepsis. The concurrent complaint of a headache necessitates a neurological assessment to check for altered mental status, meningeal signs, or focal deficits, which could indicate a serious neurological AEFI. Post-marketing surveillance data, such as that analyzed in the Brazilian mass immunization campaign, are specifically designed to capture and classify these types of events to ensure timely intervention and inform safety protocols ^[1].

Why Other Options Are Not the Priority
- Option 1: Checking the vaccination site for infection or abscess formation is an important part of a post-vaccination assessment, but it addresses a local reaction. An abscess would not develop within 2 hours and does not explain the acute systemic symptoms of fever and headache. This assessment is secondary to evaluating the patient’s overall systemic and neurological stability.
- Option 2: Assessing respiratory status and oxygen saturation is a critical component of any rapid assessment, particularly if an anaphylactic reaction is suspected. However, the scenario does not present any respiratory symptoms (e.g., wheezing, stridor, dyspnea). While a full vital sign assessment includes respiratory rate, a standalone focus on the respiratory system is not the most comprehensive initial response to the specific symptoms of fever and headache.
- Option 3: Evaluating hydration status is a relevant supportive care measure for a febrile patient, as fever increases insensible fluid loss. However, this is a secondary intervention. The immediate priority is to first determine the severity and nature of the reaction through vital signs and a neurological exam before addressing the consequences of the fever. Furthermore, the term "infant" is incorrect for a 16-year-old adolescent, making this option clinically inappropriate for the patient described.

The post-marketing surveillance framework for vaccines is built on the principle that all AEFIs, from mild to severe, must be reported and assessed systematically. The initial clinical assessment by the nurse is the first critical step in this surveillance chain, ensuring that serious events are identified and managed without delay ^[1].